DRI Healthcare to buy second royalty interest in Orserdu drug sales

DRI Healthcare entered into a purchase agreement with an affiliate of Radius Health for an upfront purchase price of $130 million.

15 August 2023•2 mins read
LinkedInXEmail
LinkedInXEmail

Related articles